Fibrinolytic therapy versus craniotomy for anticoagulant-associated intracerebral hemorrhage

Clinical Neurology and Neurosurgery

Volumn 111, Issue 6, 2009, Pages 518-522

  Rohde, Veit ^a,b   Uzma, Naureen ^a   Rohde, Ina ^a,b   St Clair, Eric ^c   Samadani, Uzma ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Anticoagulation; Fibrinolytic therapy; Intracerebral hematoma; Intracerebral hemorrhage; Neuronavigation; Stereotaxy

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIOTOMY; FEMALE; FIBRINOLYTIC THERAPY; GLASGOW COMA SCALE; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MALE; MORTALITY; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; PROGNOSIS; PUNCTURE; STEREOTACTIC TREATMENT;

ADULT; AGED; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; CRANIOTOMY; FEMALE; FIBRINOLYTIC AGENTS; GLASGOW OUTCOME SCALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; NEURONAVIGATION; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67349135610     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.02.004     Document Type: Article

References (35)

1. Barron K.D., and Fergusson G. Intracranial hemorrhage as a complication of anticoagulant therapy. Neurology 9 (1959) 447-455
2. Silverstein A. Neurological complications of anticoagulation therapy: a neurologist's review. Arch Intern Med 139 (1979) 217-220
3. Rosand J., Eckman M.H., Knudsen K.A., Singer D.E., and Greenberg S.M. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164 (2004) 880-884
4. Duff I.F., and Skull W.H. Fatal hemorrhage in dicumarol poisoning. JAMA 139 (1949) 762-766
5. Hart R.G., Boop B.S., and Anderson D.C. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26 (1995) 1471-1477
6. Flaherty M.L., Kissela B., Woo D., Kleindorfer D., Alwell K., Sekar P., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
7. Mendelow A.D., Gregson B.A., Fernandes H.M., Murray G.D., Teasdale G.M., Hope D.T., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 (2005) 387-397
8. Sjoblom L., Hardemark H.G., Lindgren A., Norrving B., Fahlen M., Samuelsson M., et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32 (2001) 2567-2574
9. Goldstein J.N., Thomas S.H., Frontiero V., Joseph A., Engel C., Snider R., et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37 (2006) 151-155
10. Fredriksson K., Norrving B., and Stromblad L.G. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23 (1992) 972-977
11. Pindur G., and Morsdorf S. The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. Thromb Res 95 (1999) S57-61
12. Vigue B., Ract C., Tremey B., Engrand N., Leblanc P.E., Decaux A., et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 33 (2007) 721-725
13. Huttner H.B., Schellinger P.D., Hartmann M., Kohrmann M., Juettler E., Wikner J., et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37 (2006) 1465-1470
14. Agarwal M.B., and Patnaik M. Recombinant activated factor VII (rFVIIa, NovoSeven). J Assoc Physicians India 53 (2005) 717-720
15. Freeman W.D., Brott T.G., Barrett K.M., Castillo P.R., Deen Jr. H.G., Czervionke L.F., et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79 (2004) 1495-1500
16. Brody D.L., Aiyagari V., Shackleford A.M., and Diringer M.N. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2 (2005) 263-267
17. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. The FTI. Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage. N Engl J Med 358 (2008) 2127-2137
18. Kase C.S., Robinson R.K., Stein R.W., DeWitt L.D., Hier D.B., Harp D.L., et al. Anticoagulant-related intracerebral hemorrhage. Neurology 35 (1985) 943-948
19. Lizuka J. Intracranial and intraspinal haematomas associated with anticoagulant therapy. Neurochirurgia (Stuttg) 15 (1972) 15-25
20. Rabinstein A.A., and Wijdicks E.F. Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurol 64 (2007) 203-206
21. Doi E., Moriwaki H., Komai N., and Iwamoto M. Stereotactic evacuation of intracerebral hematomas. Neurol Med Chir (Tokyo) 22 (1982) 461-467
22. Lippitz B.E., Mayfrank L., Spetzger U., Warnke J.P., Bertalanffy H., and Gilsbach J.M. Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 127 (1994) 157-160
23. Schaller C., Rohde V., Meyer B., and Hassler W. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 36 (1995) 328-333 discussion 333-325
24. Vereecken K.K., Van Havenbergh T., De Beuckelaar W., Parizel P.M., and Jorens P.G. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases. Clin Neurol Neurosurg 108 (2006) 451-455
25. Teernstra O.P., Evers S.M., Lodder J., Leffers P., Franke C.L., and Blaauw G. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 (2003) 968-974
26. Kothari R.U., Brott T., Broderick J.P., Barsan W.G., Sauerbeck L.R., Zuccarello M., et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27 (1996) 1304-1305
27. Kaye A.H., and Andrewes D. Glasgow Outcome Scale: research scale or blunt instrument?. Lancet 356 (2000) 1540-1541
28. Prasad K, Shrivastava A. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane database of systematic reviews (Online) 2000: CD000200.
29. Franke C.L., de Jonge J., van Swieten J.C., Op de Coul A.A., and van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke 21 (1990) 726-730
30. Radberg J.A., Olsson J.E., and Radberg C.T. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22 (1991) 571-576
31. Flibotte J.J., Hagan N., O'Donnell J., Greenberg S.M., and Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 (2004) 1059-1064
32. Levy D.E., Brott T.G., Haley Jr. E.C., Marler J.R., Sheppard G.L., Barsan W., et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25 (1994) 291-297
33. Rohde V., Rohde I., Reinges M.H., Mayfrank L., and Gilsbach J.M. Frameless stereotactically guided catheter placement and fibrinolytic therapy for spontaneous intracerebral hematomas: technical aspects and initial clinical results. Minim Invasive Neurosurg 43 (2000) 9-17
34. Thiex R., Rohde V., Rohde I., Mayfrank L., Zeki Z., Thron A., et al. Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage. J Neurol 251 (2004) 1443-1450
35. Huttner H.B., Tognoni E., Bardutzky J., Hartmann M., Kohrmann M., Kanter I.C., et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 15 (2008) 342-349